2m 2m 2m 2m 2m 2m 2m
CINGULATE (CING)
NASDAQ
$4.86+$0.10 (+2.10%)
Price as of Oct 02, 2026 7:34 PM EDT- $69.1MMarket Cap
- 13.88%1-Year Change
- BiotechnologyIndustry
CINGULATE (CING)
$4.86+$0.10 (+2.10%)
CING | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.76 | ||
Change | +$0.010 (+0.21%) | ||
Open | $4.79 | ||
High | $4.90 | ||
Low | $4.71 | ||
Previous Close | $4.75 | ||
Volume | 52,615 | ||
30-Day Average Volume | 90,760 | ||
1-Week Change | -1.45% | ||
1-Month Change | -7.57% | ||
1-Year Change | 13.88% | ||
3-Year Change | -97.13% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.5M | ||
Total Assets | $33.1M | ||
Market Cap | $69.1M | ||
Enterprise Value | $57.8M | ||
Period: QTR TTM FY | |||
Revenue | -$138,513.00 | ||
Net Income | -$5.9M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.7M | ||
EBITDA | -$5.6M | ||
Net Working Capital | $21.6M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | -417 | ||
P/B | N/A | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 08/09/2024 | ||
Earnings & Revenue